Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,509.00    -49.00 (-1.92%)
Bid:
2,523.00
Ask:
2,525.00
Spread: 2.00 (0.079%)
Market Cap: £22.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Experian appoint new independent Non-Exec Director

16 Nov 2016 15:05

RNS Number : 3714P
Experian plc
16 November 2016
 

Experian plc

 

 

Experian appoints a new independent Non-Executive Director

 

 

16 November 2016 - Experian, the global information services company, announces the appointment of a new independent Non-Executive Director to the Board of Experian plc, effective from 1 January 2017.

 

Caroline Donahue, aged 55, a US national, was Executive Vice President, Chief Marketing and Sales Officer at Intuit, the business and financial management software company based in Mountain View, California, from August 2012 until September 2016. Caroline had responsibility for bringing financial management solutions for small businesses and consumers to market across a variety of channels and markets. In addition, she ran Intuit's global go-to-market offices around the world. She previously served as Senior Vice President, Sales and Channel Marketing at Intuit since 2006 and was a Vice President and Director of Sales since 1995. Before Intuit, Caroline held sales and channel management roles at Knowledge Adventure, NeXT Computer and Apple, Inc.

 

Don Robert, Chairman of Experian, commented:

 

"I am very pleased to welcome Caroline to the Board of Experian. As well as extensive international markets and technology experience, Caroline will bring her knowledge of consumer sales and marketing, innovation and consumer-centricity to Experian. These will be invaluable as we shape our vision to place consumers at the centre of what we do. The Board will also benefit from her insight and extensive experience in mass-market, digital, multi-channel and business-to-consumer distribution, marketing, and brand and sales management."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6).

 

 

Contact:

 

Experian

Andy Simms

Head of Investor Relations

+44 (0) 20 3042 4215

Gerry Tschopp

Senior VP, Group Communications

 

Finsbury

Rollo Head

+44 (0) 20 7251 3801

Jenny Davey

 

 

About Experian 

We are the leading global information services company, providing data and analytical tools to our clients around the world. We help businesses to manage credit risk, prevent fraud, target marketing offers and automate decision making. We also help people to check their credit report and credit score, and protect against identity theft. In 2016, we were named by Forbes magazine as one of the 'World's Most Innovative Companies'.

 

We employ approximately 17,000 people in 37 countries and our corporate headquarters are in Dublin, Ireland, with operational headquarters in Nottingham, UK; California, US; and São Paulo, Brazil.

 

Experian plc is listed on the London Stock Exchange (EXPN) and is a constituent of the FTSE 100 index. Total revenue for the year ended 31 March 2016, was US$4.6 billion.

 

To find out more about our company, please visit http://www.experianplc.com or watch our documentary, 'Inside Experian'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAAKADKPBDDBDD
Date   Source Headline
18th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20268:30 amRNSBond Issue
17th Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20263:15 pmRNSAnnual Financial Report
9th Jun 20264:30 pmRNSDirector/PDMR Shareholding
8th Jun 20263:30 pmRNSDirector/PDMR Shareholding
5th Jun 202611:00 amRNSElections for Second Interim Dividend
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSNotification of issuance of equity securities
29th May 20265:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 202611:45 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSFull-year financial report
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202610:45 amRNSDirector Declaration
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20265:38 pmRNSNotification of issuance of equity securities
30th Apr 20265:14 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSChair appointment
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.